EPM speaks to Nigel Skinner, Marketing Director at Andrew Alliance about how automation is being used throughout the pharma industry and how it is helping bring new drugs to market faster.
Tania Pereira Chilima, CTO at Univercells Technologies examines the challenges gene therapies face during production and how integrated and continuous processing can help.
Mario Pereira, field application scientist for bioproduction at Horizon Discovery, a PerkinElmer company, comments on the advantages of using CHO cells for biomanufacturing and explains how gene editing technologies are increasing their utility.
Damiano Rossi, head of Applications – Particle Engineering and Microfluidics, Dolomite Microfluidics looks at how computational fluid dynamics modelling and AI are helping scientists predict the outcomes of microfluidic experiments.
Stuart Madden, chief scientific officer at neuroscience company Neurelis, examines the drug delivery sector and the opportunities non-invasive methods present to the industry and patients.
European Pharmaceutical Manufacturer editor Reece Armstrong looks at the antibiotics landscape and why we need to speak up about antimicrobial resistance (AMR).
In this episode of The MedTalk Podcast, Ian Bolland joined by Liz Ashall-Payne, founding chief executive of ORCHA to discuss the digital health landscape and its acceleration during Covid-19.
Ben Wylie, senior product manager at ChargePoint Technology, argues that single-use (SU) technology is central to helping biotechs optimise efficiency in order to meet fast-growing demand for biologic treatments.
